Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOnward Opps Regulatory News (ONWD)

Share Price Information for Onward Opps (ONWD)

Share Price is delayed by 15 minutes
Get Live Data
123.50    0.00 (0.00%)
Bid:
122.00
Ask:
125.00
Spread: 3.00 (2.459%)
Market Cap: £41.18m
ONWD Live PriceLast checked at - London Stock Exchange

Intraday Onward Opps Share Chart

Net Asset Value(s)

4 Mar 2025 16:59

RNS Number : 3327Z
Onward Opportunities Limited
04 March 2025
 

4 March 2025

 

Onward Opportunities Limited

("Onward Opportunities" or the "Company")

 

 

Net Asset Value

 

Onward Opportunities announces that as at 28 February 2025, the unaudited net asset value ("NAV") per ordinary share was 122.83 pence, a decrease of 2.51% versus the previous month end.

 

The above NAV calculation is based on the Company's issued share capital as at 28 February 2025 of 23,979,754 ordinary shares of no par value.

 

For further information, please contact:

 

 

Onward Opportunities Limited

Andrew Henton, Chairman

 

Dowgate Wealth Limited (Portfolio Manager)

Laurence Hulse, Investment Director

 

 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

 

 

SEC Newgate (Financial Communications)

Bob Huxford / Molly Gretton

 

Tel: +44 (0) 203 757 6880

onward@secnewgate.co.uk

Apex Fund and Corporate Services (Guernsey) Limited (Company Secretary)

James Taylor / Tanya Kinnear

Tel: +44 (0) 203 5303 600

ool@apexgroup.com

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Ben Jeynes / Camilla Hume

 

Tel: +44 (0)20 7200 0500

Dowgate Capital Limited (Joint Broker)

Nicholas Chambers / Russell Cook

 

Tel: +44 (0)20 3903 7715

 

 

About Onward Opportunities

Onward Opportunities is an investment company focussed on the UK small cap market, led by an Investment Committee and Lead Manager with over 160 years' combined experience.

Onward has a clear investment strategy, to capitalise on the significant valuation anomalies arising from a lack of investor information on UK small and micro-cap stocks. Through its analysis, experience and deep understanding of the UK Small Cap market, Onward Opportunities is able to identify these anomalies, enabling investment in opportunities with superior potential upside.

The investment philosophy is to focus on companies with competitive advantage, strong management track record, balance sheet asset backing, attractive cash flow potential and visibility of earnings. Investee companies will also have scope for material potential valuation upside that can be delivered from catalysing strategic, operational or management initiatives. Onward Opportunities helps its portfolio companies realise this potential through active engagement.

Since IPO in March 2023, the investment strategy and philosophy have proven successful, consistently outperforming the AIM All Share Index. Onward Opportunities' investment objective is to deliver a return on investments of at least 2.0x invested capital over a three-to-five-year hold period, aggregating into a total annualised return of at least 15% per annum.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVUPURAWUPAGQC
12
Date   Source Headline
4th Jun 202611:57 amRNSNet Asset Value(s)
2nd Jun 202612:26 pmRNSPublication of May 2026 Factsheet
1st Jun 202612:03 pmRNSNet Asset Value(s)
28th May 202612:12 pmRNSNet Asset Value(s)
21st May 202611:34 amRNSNet Asset Value(s)
14th May 202612:17 pmRNSNet Asset Value(s)
8th May 20267:00 amRNSDirector/PDMR Shareholding
7th May 20264:39 pmRNSPurchase of Shares by the Portfolio Manager
7th May 20263:51 pmRNSPublication of April 2026 Factsheet - Replacement
7th May 202612:44 pmRNSPublication of April 2026 Factsheet
7th May 202611:50 amRNSNet Asset Value(s)
1st May 202611:31 amRNSNet Asset Value(s)
1st May 20267:01 amRNSTotal Voting Rights
1st May 20267:00 amRNSIssue of Equity
30th Apr 202611:54 amRNSNet Asset Value(s)
24th Apr 20267:00 amRNSIssue of Equity
23rd Apr 202611:54 amRNSNet Asset Value(s)
21st Apr 20262:12 pmRNSHolding(s) in Company
21st Apr 202610:24 amRNSPublication of Q1 2026 Factsheet
20th Apr 20269:05 amRNSBlock Admission Application
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSDirector/PDMR Shareholding
16th Apr 20261:10 pmRNSNet Asset Value(s)
16th Apr 20268:00 amRNSReadmission - Onward Opportunities Limited
16th Apr 20267:00 amRNSAdmission to Main Market and AIM Cancellation
15th Apr 20269:29 amRNSResult of AGM
14th Apr 20262:46 pmRNSPurchase of Shares by Portfolio Manager
13th Apr 202612:19 pmRNSPublication of a Prospectus
9th Apr 20265:30 pmRNSOnward Opportunities
1st Apr 20264:13 pmRNSNet Asset Value(s)
26th Mar 202611:25 amRNSUpdate re Main Market Listing and Notice of AGM
2nd Mar 20264:56 pmRNSNet Asset Value(s)
2nd Mar 20267:00 amRNSIntended Main Market Listing
2nd Mar 20267:00 amRNSAnnual Results
5th Feb 20268:39 amRNSChange of Adviser
2nd Feb 20264:45 pmRNSNet Asset Value(s)
21st Jan 20264:04 pmRNSHolding(s) in Company - Replacement
21st Jan 20269:52 amRNSHolding(s) in Company
20th Jan 202610:34 amRNSHolding(s) in Company
19th Jan 20267:00 amRNSAdditional Subscription and Total Voting Rights
12th Jan 20267:00 amRNSIssue of Equity
12th Jan 20267:00 amRNSFull-Year Update
6th Jan 202612:00 pmRNSPublication of Q4 2025 Factsheet
2nd Jan 20264:05 pmRNSNet Asset Value(s)
31st Dec 202512:14 pmRNSHolding(s) in Company
31st Dec 202512:14 pmRNSHolding(s) in Company
4th Dec 20251:21 pmRNSDirector/PDMR Shareholding
1st Dec 20254:04 pmRNSNet Asset Value(s)
25th Nov 202511:34 amRNSHolding(s) in Company
19th Nov 20257:00 amRNSAdditional Subscription and Total Voting Rights
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.